HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Christelle Levy Selected Research
Christelle Levy Research Topics
Disease
66
Breast Neoplasms (Breast Cancer)
03/2024 - 10/2006
20
Neoplasms (Cancer)
01/2023 - 11/2011
8
Fatigue
01/2023 - 11/2011
6
Triple Negative Breast Neoplasms
01/2023 - 11/2018
6
Inflammatory Breast Neoplasms
08/2022 - 12/2006
3
Pain (Aches)
08/2023 - 10/2020
3
Neutropenia
11/2022 - 10/2006
3
Neoplasm Metastasis (Metastasis)
01/2022 - 10/2006
3
Diarrhea
01/2021 - 07/2017
2
Lymphopenia (Lymphocytopenia)
11/2022 - 01/2022
2
Disease Progression
11/2022 - 04/2021
1
Cardiotoxicity
03/2024
1
Amenorrhea
11/2023
1
Sleep Initiation and Maintenance Disorders (Insomnia)
11/2023
1
Lymphedema (Milroy Disease)
03/2022
1
COVID-19
03/2022
1
Circulating Neoplastic Cells
09/2021
1
Nausea
01/2021
1
Cytopenia
01/2021
1
Vomiting
01/2021
1
Cognitive Dysfunction
02/2020
1
Atrophy
02/2020
1
Infections
11/2018
Drug/Important Bio-Agent (IBA)
13
Hormones (Hormone)
IBA
08/2023 - 02/2016
8
Trastuzumab (Herceptin)
FDA Link
03/2024 - 04/2016
8
ErbB Receptors (EGF Receptor)
IBA
10/2023 - 10/2018
6
human ERBB2 protein
IBA
06/2023 - 10/2013
6
Paclitaxel (Taxol)
FDA Link
Generic
01/2022 - 10/2018
6
Bevacizumab (Avastin)
FDA Link
01/2021 - 12/2014
5
Phenobarbital (Luminal)
FDA Link
01/2022 - 12/2018
4
Anthracyclines
IBA
03/2024 - 10/2006
4
taxane
IBA
10/2023 - 10/2006
4
Epirubicin (Ellence)
FDA Link
Generic
11/2019 - 12/2006
3
pertuzumab
IBA
10/2023 - 07/2017
3
Taxoids (Taxanes)
IBA
01/2023 - 02/2014
3
DNA (Deoxyribonucleic Acid)
IBA
11/2022 - 03/2014
3
palbociclib
IBA
11/2022 - 01/2022
3
Circulating Tumor DNA
IBA
01/2022 - 10/2016
3
Cyclophosphamide (Cytoxan)
FDA Link
Generic
11/2019 - 01/2017
3
Fluorouracil (Carac)
FDA Link
Generic
11/2019 - 10/2006
2
margetuximab
IBA
10/2023 - 04/2021
2
Letrozole (Femara)
FDA Link
Generic
11/2022 - 01/2022
2
Anastrozole (Arimidex)
FDA Link
Generic
11/2022 - 02/2016
2
Aromatase Inhibitors
IBA
11/2022 - 02/2016
2
Fulvestrant (Faslodex)
FDA Link
11/2022 - 01/2021
2
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
03/2022 - 01/2020
2
4-amino-4'-hydroxylaminodiphenylsulfone (HADS)
IBA
01/2022 - 01/2021
2
amitraz (Taktic)
IBA
01/2022 - 12/2021
2
70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)
IBA
01/2022 - 12/2021
2
Cyclin-Dependent Kinase 4
IBA
01/2022 - 01/2022
2
Vinorelbine (Navelbine)
FDA Link
Generic
07/2020 - 10/2006
2
Tamoxifen
FDA Link
Generic
01/2020 - 02/2016
2
Progesterone Receptors (Progesterone Receptor)
IBA
01/2020 - 11/2018
2
Docetaxel (Taxotere)
FDA Link
11/2019 - 11/2018
1
Maytansine (Maitansine)
IBA
10/2023
1
Everolimus
FDA Link
02/2023
1
ORALIT (ORS)
IBA
01/2023
1
trastuzumab deruxtecan
IBA
01/2023
1
Platinum
IBA
11/2022
1
exemestane (Aromasin)
FDA Link
11/2022
1
COVID-19 Vaccines
IBA
03/2022
1
Cyclin-Dependent Kinases (cdk Proteins)
IBA
01/2022
1
TOR Serine-Threonine Kinases
IBA
01/2022
1
Indicators and Reagents (Reagents)
IBA
01/2022
1
Ribosomal Protein S6 Kinases (S6 Kinase)
IBA
01/2022
1
reparixin
IBA
11/2021
1
Biomarkers (Surrogate Marker)
IBA
09/2021
1
Colony-Stimulating Factors (Colony Stimulating Factor)
IBA
06/2021
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
06/2021
1
durvalumab
IBA
01/2021
1
Haptoglobins
IBA
01/2021
1
Antibodies
IBA
01/2021
1
Gemcitabine
FDA Link
01/2021
1
B7-H1 Antigen
IBA
01/2021
1
Alpelisib
IBA
01/2021
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2020
1
Monoclonal Antibodies
IBA
01/2020
1
Estrogen Receptors
IBA
01/2020
1
pembrolizumab
IBA
01/2020
1
eribulin
FDA Link
12/2019
1
Etoposide (VP 16)
FDA Link
Generic
01/2019
1
ixabepilone (BMS 247550)
FDA Link
11/2018
1
Loperamide (Imodium)
FDA Link
Generic
10/2018
1
lumretuzumab
IBA
10/2018
1
Protons (Proton)
IBA
02/2018
1
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2017
1
Matrix Metalloproteinases (MMPs)
IBA
04/2016
Therapy/Procedure
27
Drug Therapy (Chemotherapy)
03/2024 - 02/2014
17
Therapeutics
11/2023 - 11/2011
8
Radiotherapy
08/2023 - 11/2011
8
Adjuvant Chemotherapy
02/2020 - 11/2011
7
Neoadjuvant Therapy
03/2024 - 01/2016
2
Maintenance Chemotherapy
01/2021 - 12/2006
1
Drug Tapering
01/2023
1
Art Therapy
01/2022
1
Cognitive Training
12/2020
1
Palliative Care (Palliative Therapy)
01/2020
1
Segmental Mastectomy (Lumpectomy)
04/2019
1
Proton Therapy
02/2018
1
Lymph Node Excision (Lymph Node Dissection)
01/2017